{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:14:38Z","timestamp":1790252078317,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmcl.2025.130352","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:37:53Z","timestamp":1753832273000},"page":"130352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of the new active ingredient tigolaner, an allosteric modulator of the GABA-gated chloride channel for use as a spot-on ectoparasiticide in animal health"],"prefix":"10.1016","volume":"128","author":[{"given":"Anne","family":"D\u00e9cor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Ebbinghaus-Kintscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Raming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Turberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Mencke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Hahn","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Hallenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"K\u00f6bberling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"H\u00fcbsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bretschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Ilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"L\u00f6sel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"G\u00f6rgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"W\u00f6lfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Adamczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bmcl.2025.130352_bb0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pt.2020.09.004","article-title":"Antiparasitics in Animal Health: Quo Vadis?","volume":"37","author":"Selzer","year":"2022","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmcl.2025.130352_bb0010","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.3390\/ijerph17113789","article-title":"A one health perspective on the human\u2013companion animal relationship with emphasis on zoonotic aspect","volume":"17","author":"Overgaauw","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130352_bb0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbrc.2009.11.131","article-title":"The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels","volume":"391","author":"Ozoe","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2025.130352_bb0025","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.bmcl.2013.03.031","article-title":"4-Azolylphenyl isoxazoline insecticides acting at the GABA gated chloride channel","author":"Lahm","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130352_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pestbp.2018.02.002","article-title":"Fluxametamide: A novel isoxazoline insecticide that acts via distinctive antagonism of insect ligand-gated chloride channels","volume":"151","author":"Asahia","year":"2018","journal-title":"Pestic Biochem Physiol"},{"key":"10.1016\/j.bmcl.2025.130352_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/B978-0-12-821035-2.00008-5","article-title":"The discovery of isocycloseram: A novel isoxazoline insecticide","volume":"9","author":"Cassayre","year":"2021","journal-title":"Recent highlights in the discovery and optimization of crop protection product"},{"key":"10.1016\/j.bmcl.2025.130352_bb0040","series-title":"Halogen-substituted pyrazole derivatives as pest-control agents, WO 2014\/122083 Al","author":"Maue","year":"2014"},{"key":"10.1016\/j.bmcl.2025.130352_bb0045","first-page":"245","article-title":"Mode of Action of Novel Insecticides","volume":"10","author":"Madesh","year":"2024","journal-title":"Advanced Trends in Plant Protection"},{"key":"10.1016\/j.bmcl.2025.130352_bb0050","year":"2025"},{"key":"10.1016\/j.bmcl.2025.130352_bb0055","series-title":"Novel halogen-substituted compounds WO 2010\/051926 A8","author":"Maue","year":"2010"},{"key":"10.1016\/j.bmcl.2025.130352_bb0060","series-title":"Variations in the Insect GABA Receptor, RDL, and Their Impact on Receptor Pharmacology. Advances in Agrochemicals: Ion Channels and G Protein-Coupled Receptors (GPCRs) as Targets for Pest Control ACS Symposium Series","author":"Taylor-Wells","year":"2017"},{"key":"10.1016\/j.bmcl.2025.130352_bb0065","series-title":"N-(3-Carbamoylphenyl)-lH-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests, WO 2012\/126766 A1","author":"Maue","year":"2012"},{"key":"10.1016\/j.bmcl.2025.130352_bb0070","series-title":"Novel Halogen-substituted compounds. US 2017\/0137413 A","author":"Maue","year":"2017"},{"key":"10.1016\/j.bmcl.2025.130352_bb0075","series-title":"Insecticidal compounds. WO 2012\/107434 A1","author":"Jung","year":"2012"},{"key":"10.1016\/j.bmcl.2025.130352_bb0080","series-title":"Halogen-substituted compounds, US2011\/301181 A1","author":"Maue","year":"2011"},{"key":"10.1016\/j.bmcl.2025.130352_bb0085","first-page":"100","article-title":"Multicenter randomized, and blinded European field study evaluating the efficacy and safety of Felpreva\u00ae, a novel spot-on formulation containing emodepside, praziquantel and tigolaner, in treating cats naturally infested with fleas and\/or ticks","volume":"2","author":"Cvejic","year":"2023","journal-title":"Current Research in Parasitology & Vector-Borne Diseases"},{"key":"10.1016\/j.bmcl.2025.130352_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.crpvbd.2023.100122","article-title":"Immediate and long-term efficacy of Felpreva\u00ae, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with the cat flea Ctenocephalides felis","volume":"3","author":"Mencke","year":"2023","journal-title":"Current Research in Parasitology & Vector-Borne Diseases"},{"key":"10.1016\/j.bmcl.2025.130352_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.crpvbd.2023.100123","article-title":"efficacy and safety of Felpreva\u00ae, a spot-on formulation for cats containing emodepside, praziquantel and tigolaner against experimental infestation with the Australian paralysis tick Ixodes holocyclus","volume":"4","author":"Roeber","year":"2023","journal-title":"Current Research in Parasitology & Vector-Borne Diseases"},{"key":"10.1016\/j.bmcl.2025.130352_bb0100","article-title":"Efficacy of Felpreva\u00ae, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with ear mites (Otodectes cynotis)","volume":"4","author":"Blazejak","year":"2023","journal-title":"Current Research in Parasitology & Vector-Borne Diseases"},{"key":"10.1016\/j.bmcl.2025.130352_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.crpvbd.2023.100146","article-title":"Field efficacy and safety of Felpreva\u00ae (tigolaner, emodepside and praziquantel) spot-on for the treatment of natural ear mite infestations (Otodectes cynotis) and notoedric mange (Notoedres cati) in cats","volume":"4","author":"Blazejak","year":"2023","journal-title":"Current Research in Parasitology & Vector-Borne Diseases"},{"key":"10.1016\/j.bmcl.2025.130352_bb0110","series-title":"Plasma pharmacokinetics of tigolaner, emodepside, and praziquantel following topical administration of a combination product (Felpreva\u00ae) and of intravenous administration of the individual active ingredients in cats","volume":"4","author":"Mencke","year":"2023"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:18:47Z","timestamp":1776917927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25002616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":21,"alternative-id":["S0960894X25002616"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130352","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of the new active ingredient tigolaner, an allosteric modulator of the GABA-gated chloride channel for use as a spot-on ectoparasiticide in animal health","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130352"}}